Comparing the Relationship Between BDNF, VEGF and Body Composition Factors in Obese and Normal Weight Men

Document Type : Original Article

Authors

1 Department of Physical Education and Sport Sciences, Faculty of Education and Psychology, University of Mohaghegh Ardabili, Ardabil, Iran.

2 Faculty of Science, University of Mohaghegh Ardabili, Ardabil, Iran.

3 Master of Sport Physiology, Department of Physical Education and Sport Sciences, Faculty of Education and Psychology, University of Mohaghegh Ardabili, Ardabil, Iran.

Abstract

Background and Aims: The background of most metabolic diseases is obesity and overweight. The purpose of this study was to compare the relationship between Brain-Derived Neurotrophic Factor (BDNF), Vascular Endothelial Growth Factor (VEGF) and body composition factors in obese and normal-weight men.
Method: In this semi-experimental study, 12 obese (Age:33.50±1.44, Weight: 98.66±4.75, BMI: 32.96±1.71) and 11 normal-weight (Age; 32.45±1.75, Weight: 74.81±6.16, BMI: 23.82±0.55) men participated in this study. At first, anthropometrical (weight, height, and body composition factors [(body fat percentage (BF%), body fat weight (BFW), and lean body weight (LBW)] data were measured. Then, saliva samples were collected via unstimulated passive drool over five minutes. The analysis of BDNF and VEGF was performed using a sandwich enzyme-linked immunosorbent assay (ELISA).
Results: A significant difference was observed for a mean of BDNF, VEGF, weight, BF%, BFW, and LBW between the two groups (P<0.05). Correlation analyses in obese and normal weight groups between saliva VEGF levels and BMI were positive significant (r = .63; P = 0.03). In normal weight group, there were negative significant correlation between BDNF and BMI (r = -.65; P = 0.02).
Conclusion: Based on the results of the present study it can be concluded that the difference between the saliva levels of BDNF and VEGF of obese and normal-weight beginner aerobics men is partly due to body composition factors and lower BDNF and higher VEGF in obese men might be due to their body composition and weight.

Keywords

  1. Kelly T, Yang W, Chen C-S, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32(9):1431-7.
  2. Güngör NK. Overweight and obesity in children and adolescents. J Clin Res Pediatr Endocrinol. 2014;6(9):129.
  3. Han JC, Lawlor DA, Kimm SY. Childhood obesity. Lancet. 2010;375(8):1737-48.
  4. Gutin B, Ramsey L, Barbeau P, Cannady W, Ferguson M, Litaker M, et al. Plasma leptin concentrations in obese children: changes during 4-mo periods with and without physical training. Am J Clin Nutr. 1999;69(11):388-94.
  5. Lee D, Sui X, Ortega F, Kim Y, Church T, Winett R, et al. Comparisons of leisure-time physical activity and cardiorespiratory fitness as predictors of all-cause mortality in men and women. Br J Sports Med. 2011;45(9):504-10.
  6. Ding Y-H, Li J, Zhou Y, Rafols JA, Clark JC, Ding Y. Cerebral angiogenesis and expression of angiogenic factors in aging rats after exercise. Curr Neurovasc Res. 2006;3(5):15-23.
  7. Kermani P, Rafii D, Jin DK, Whitlock P, Schaffer W, Chiang A, et al. Neurotrophins promote revascularization by local recruitment of TrkB+ endothelial cells and systemic mobilization of hematopoietic progenitors. J Clin Invest. 2005;115(7):653-63.
  8. Spartano NL, Davis-Plourde KL, Himali JJ, Murabito JM, Vasan RS, Beiser AS, et al. Self-Reported Physical Activity and Relations to Growth and Neurotrophic Factors in Diabetes Mellitus: The Framingham Offspring Study. J Diabetes Res. 2019;2019.
  9. Paillard T, Rolland Y, de Souto Barreto P. Protective effects of physical exercise in Alzheimer’s disease and Parkinson’s disease: a narrative review. J Clin Neurol. 2015;11(9):212-9.
  10. Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res. 2000;55(6):15-22.
  11. Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest. 2007;117(10):2362-8.
  12. García de la Torre N, Rubio MA, Bordiu E, Cabrerizo L, Aparicio E, Hernández C, et al. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J Clin Endocrinol Metab. 2008;93(4):4276-81.
  13. Wada H, Satoh N, Kitaoka S, Ono K, Morimoto T, Kawamura T, et al. Soluble VEGF receptor-2 is increased in sera of subjects with metabolic syndrome in association with insulin resistance. Atherosclerosis. 2010;208(12):512-7.
  14. Sandhofer A, Tatarczyk T, Kirchmair R, Iglseder B, Paulweber B, Patsch J, et al. Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study. Atherosclerosis. 2009;206(14):265-9.
  15. Kimura K, Hashiguchi T, Deguchi T, Horinouchi S, Uto T, Oku H, et al. Serum VEGF—as a prognostic factor of atherosclerosis. Atherosclerosis. 2007;194(9):182-8.
  16. Silha J, Krsek M, Sucharda P, Murphy L. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond). 2005;29(6):1308-14.
  17. Duggan C, Xiao L, Wang C-Y, McTiernan A. Effect of a 12-month exercise intervention on serum biomarkers of angiogenesis in postmenopausal women: a randomized controlled trial. Cancer Epidemiol Biomarkers Prev. 2014;23(9):648-57.
  18. Kowiański P, Lietzau G, Czuba E, Waśkow M, Steliga A, Moryś J. BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol Neurobiol. 2018;38(13):579-93.
  19. Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, et al. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol. 2011;14(7):347-53.
  20. Cho H-c, Kim J, Kim S, Son YH, Lee N, Jung SH. The concentrations of serum, plasma and platelet BDNF are all increased by treadmill VO2max performance in healthy college men. Neurosci Lett. 2012;519(10):78-83.
  21. Araki S, Yamamoto Y, Dobashi K, Asayama K, Kusuhara K. Decreased plasma levels of brain-derived neurotrophic factor and its relationship with obesity and birth weight in obese Japanese children. Obes Res Clin Pract. 2014;8:e63-e9.
  22. Roth CL, Elfers C, Gebhardt U, Müller HL, Reinehr T. Brain-derived neurotrophic factor and its relation to leptin in obese children before and after weight loss. Metabolism. 2013;62(6):226-34.
  23. Ono M, Itakura Y, Nonomura T, Nakagawa T, Nakayama C, Taiji M, et al. Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice. Metabolism. 2000;49(11):129-33.
  24. Tsuchida A, Nakagawa T, Itakura Y, Ichihara J, Ogawa W, Kasuga M, et al. The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice. Diabetologia. 2001;44(10):555-66.
  25. Kernie SG, Liebl DJ, Parada LF. BDNF regulates eating behavior and locomotor activity in mice. The EMBO journal. 2000;19(9):1290-300.
  26. Jackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr. 1978;40(7):497-504.
  27. Ferris LT, Williams JS, Shen C-L. The effect of acute exercise on serum brain-derived neurotrophic factor levels and cognitive function. Med Sci Sports Exerc. 2007;39(6):728-36.
  28. El-Gharbawy AH, Adler-Wailes DC, Mirch MC, Theim KR, Ranzenhofer L, Tanofsky-Kraff M, et al. Serum brain-derived neurotrophic factor concentrations in lean and overweight children and adolescents. J Clin Endocrinol Metab. 2006;91(8):3548-52.
  29. Lee I-T, Lee W-J, Tsai I-C, Liang K-W, Lin S-Y, Wan C-J, et al. Brain-derived neurotrophic factor not associated with metabolic syndrome but inversely correlated with vascular cell adhesion molecule-1 in men without diabetes. Clinica Chimica Acta. 2012;413(1):944-8.
  30. Swift DL, Johannsen NM, Myers VH, Earnest CP, Smits JA, Blair SN, et al. The effect of exercise training modality on serum brain derived neurotrophic factor levels in individuals with type 2 diabetes. PLoS One. 2012;7:e42785.
  31. Babaei P, Damirchi A, Mehdipoor M, Tehrani BS. Long term habitual exercise is associated with lower resting level of serum BDNF. Neurosci Lett. 2014;566(2):304-8. [In Persian]
  32. Nazari Y, Nikbakht M, Habibi A, Shakeryan S. Acute and Chronic Effects of Combined Training on Brain-Derived Neurotrophic Factor Levels and Its Association with Anthropometric Variables in Overweight Men. Ann Mil Health Sci Res. 2016;14:e13037. [In Persian]
  33. Hristova M. Metabolic syndrome–from the neurotrophic hypothesis to a theory. Med Hypotheses. 2013;81(3):627-34.
  34. Marti A, Santos J, Gratacos M, Moreno-Aliaga M, Maiz A, Martinez J, et al. Association between leptin receptor (LEPR) and brain-derived neurotrophic factor (BDNF) gene variants and obesity: a case-control study. Nutr Neurosci. 2009;12(4):183-8.
  35. Loebig M, Klement J, Schmoller A, Betz S, Heuck N, Schweiger U, et al. Evidence for a relationship between VEGF and BMI independent of insulin sensitivity by glucose clamp procedure in a homogenous group healthy young man. PLoS One. 2010;5:e12610.
  36. Oranskiy SP, Yeliseyeva LN, Tsanaeva AV, Zaytseva NV. Body composition and serum levels of adiponectin, vascular endothelial growth factor, and interleukin-6 in patients with rheumatoid arthritis. Croat Med J. 2012;53(8):350-6.
  37. Gold SM, Schulz K-H, Hartmann S, Mladek M, Lang UE, Hellweg R, et al. Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls. J Neuroimmunol. 2003;138(11):99-105.